https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75262008000600013
ACTA DE LA COMISIÓN DE PREMIOS AÑO 2007

REV CHIL OBSTET GINECOL 2008; 73(6): 423 - 425

 

Crónica

ACTA DE LA COMISIÓN DE PREMIOS AÑO 2007

  En Santiago de Chile, con fecha    7 de Octubre de 2008, a las 17:30 horas, se reúne la Comisión de Premios formada    de acuerdo a los artículos 26, 27 y 29 de los Estatutos de la Sociedad Chilena    de Obstetricia y Ginecología.

El Jurado constituido por el Presidente de la    Sociedad Dr. Eugenio Suárez P. por los Miembros de la Comisión Dr. Pablo Escudero    B. y Dr. Enrique Guiloff F., y por el Secretario General, Dr. Hernán Muñoz S.,    éste último con derecho a voz solamente; acuerdan otorgar los siguientes premios    correspondientes al año 2007.

Premio "DR. JORGE DÍAZ BRAVO" año    2007, al mejor trabajo de Ingreso: "PREVALENCIA DE PROCEDIMIENTOS INVASIVOS    EN UNA POBLACIÓN CHILENA USUARIA DE MÉTODOS DE CRIBADO Y DIAGNOSTICO PRENATAL"de    los Drs. Mauro Parra C, Lorena Quiroz V., Sebastián Pérez B., Carlos Raú    M., Rodrigo Térra A., Daniel Pedraza S., Hernán Muñoz S., Enrique Valdés R.    Unidad de Medicina Mater-no-Fetal, Hospital Clínico José Joaquín Aguirre, Facultad    de Medicina Universidad de Chile.

Premio "DR. JUAN MALFANTI"año    2007, al mejor trabajo de casuística: Este premio se declaró desierto.

"Mención Honrosa" del premio    "Dr. Juan Malfanti" año 2007, al trabajo: "PRONOSTICO    NEONATAL DEL RECIÉN NACIDO DE MUY BAJO PESO: HOSPITAL REGIONAL DE PUERTO MONTT    2000-2005" de los Drs. José Caro M., Gerardo Flores H. Erika Ortiz F.,    Carlos Anwandter Sch., Daniel Rodríguez A.

Premio "DR. JUAN WOOD WALTERS"año    2007, al mejor trabajo de Ginecología: "CÁNCER CERVI-COUTERINO ESTADIO    III B TRATADO CON RA-DIOQUIMIOTERAPIA CONCOMITANTE BASADA EN CISPLATINO. EXPERIENCIA    INICIAL HOSPITAL CARLOS VAN BURÉN de los Drs. José Solis C, Ménica Silva V.,    Marielisa León P., Guillermo Merino H., Rodrigo Díaz B., Erasmo Bravo O., Christian    Franck K., Javier Egaña F. Servicio de Oncología, Hospital Carlos Van Burén,    Cátedra de Oncología, Escuela de Medicina,    Universidad de Valparaíso, Servicio de Ginecología y Obstetricia, Hospital Carlos    Van Burén, Cátedra de Ginecología y Obstetricia Escuela de Medicina, Universidad    de Valparaíso.

Mención Honrosa del Premio "Dr. Juan    Wood Wal-ters"año 2007, al trabajo: "IMPORTANCIA DE LACIS-TOSCOPIA    PARA ASEGURAR LA INDEMNIDAD DE LOS URÉTERES DESPUÉS DE CIRUGÍA VAGINAL"    de los Drs. Jack Pardo S., Vicente Sola D., Paolo Ricci A. Enrique Guiloff F.    Unidad de Uroginecología y Cirugía Vaginal, Departamento de Ginecología y Obstetricia,    Clínica Las Condes.

Premio "DR. VÍCTOR MANUEL GAZITÚA GUZ-MÁN"    año 2007, al mejor trabajo de Obstetricia: Este premio se declaró desierto.

Mención Honrosa del premio "Dr. Víctor    Manuel Gacitúa Guzmán" año 2007, al trabajo: "EMBARAZO ECTOPICO:    FACTORES DE RIESGO Y CARACTERÍSTICAS CLÍNICAS DE LA ENFERMEDAD EN UN GRUPO DE    MUJERES CHILENAS" de los autores María Teresa Urrutia S., Lauren Poupin    B., Paula Alar-cón A., Magdalena Rodríguez C, Loreto Stuven R., del Departamento    de Salud de la Mujer, Escuela de Enfermería, Facultad de Medicina, Pontificia    Universidad Católica de Chile.

Premio "DR. CARLOS MONCKEBERG BRAVO"    año 2007, al mejor trabajo de Perinatología: "RESULTADO NEONATAL ADVERSO    EN LA ROTURA PREMATURA DE MEMBRANAS DE PRETERMINO SEGÚN EL MODO DE PARTO"    de los Drs. Alfredo Ovalle S., M. Angélica Martínez T., Ariel Fuentes G., Elena    Kakarieka W., Carlos Aspillaga M., Ricardo Saavedra M., Sebastian Medel C. del    Servicio y Departamento de Obstetricia, Ginecología y neonatología Hospital    San Borja Arriarán, facultad de Medicina Universidad de Chile, programa de Microbiología    I.C.B.M. Facultad de Medicina Universidad de Chile, Servicio de Anatomía patológica    Hospital San Borja Arriarán.

Para dejar constancia firman: Drs. Enrique Guiloff,    Pablo Escudero, Hernán Muñoz, Eugenio Suárez.

International Consortium    for Emergency Contraceptíon (ICEC)        International Federatíon of Gynecology & Obstetrics (FIGO)  Statement on Mechanism ofAction (October    2008)

How do levonorgestrel-only emergency    contraceptive pills (LNG ECPs) prevent pregnancy?

Levonorgestrel-only emergency contraceptive    pills:

 Inhibit or delay an egg from being    released from the ovary when taken before ovulation;      Possibly prevent the sperm    and the egg from meeting by affecting the cervical mucus or the ability of sperm    to bind to the egg.

The Evidence:

Ovulation:

 A number of studies provide strong direct    evidence that LNG ECPs prevent or delay ovulation. If taken before ovulation,    LNG ECPs inhibit the pre-ovulatory luteinizing hormone (LH) surge, impeding    follicular development and maturation and/or the reléase of the egg itself.1-7    This is the primary and possibly the only mechanism of action for LNG ECPs

Implantation:

 One study has estimated effectiveness    of LNG ECPs by confirming the cycle day by hormonal analysis (other studies    used women s self-reported cycle date). In this study, pregnancies occurred    only in women who took ECPs on or after the day of ovulation, while no pregnancies    occurred in the women who took ECPs before ovulation, providing evidence that    ECPs were unable to prevent implantation.8

 A number of studies have evaluated whether    ECPs produce changes in the histological and biochemical characteristics of    the endometrium. Most studies show that LNG ECPs have no such eífect on the    endometrium, indicating that they have no mechanism to prevent implantation.1,2'9    One study found a single altered endometrial parameter only when LNG was administered    prior to the LH surge, at a time when ECPs inhibit ovulation.10

 One study showed that levonorgestrel did    not prevent the attachment of human embryos to a simulated (in vitro) endometrial    environment.11

 Animal studies demonstrated that LNG ECPs    did not prevent implantation of the fertilized egg in the endometrium.12,    13

Sperm:

 LNG ECPs may interfere with sperm motility    by thickening the cervical mucus, which prevents sperm from reaching the egg,    thus inhibiting fertilization.14, 15 Levonorgestrel may also affect    the ability of sperm to bind to an egg.16

 However, a recent study did not find any    eífect of LNG on the number of viable sperm found in the uterine flushings taken    36-60 hours after coitus and 24-48 hours after taking LNG ECPs.17

 Research on the eífect of LNG ECPs on    sperm is inconclusive.

Other facts:

 Emergency contraceptíon is not the same    as early medical abortion. EC is eífective only in the first few days following    intercourse before the ovum is released from the ovary and before the sperm    fertilizes the ovum. Medical abortion is an option for women in the early stage    of an established pregnancy, but requires a diíferent drug from levonorgestrel.

 EC cannot interrupt an established pregnancy    or harm a developing embryo.18,19

Please visit www.cecinfo.org    or www.figo.org

Implications of the research:

 Inhibition or delay of ovulation is LNG    ECPs principal mechanism of action.      Review of the evidence suggests    that LNG ECPs cannot prevent implantation of a fertilized egg. Language on implantation    should not be included in LNG ECP product labeling.      The fact that LNG ECPs have no demonstrated    effect on implantation explains why they are not 100% effective in preventing    pregnancy, and are less effective the later they are taken. Women should be    given a clear message that ECPs are more effective the sooner they are taken.      ECPs do not interrupt a pregnancy    (by any definition of the beginning of pregnancy). However, ECPs can prevent    abortions by reducing unwanted pregnancies.

REFERENCES

1. Marions L, Hultenby K, Lindell I, Sun    X, Stabi B, Gemzell Danielsson K. Emergency contraception with mifepristone    and levonorgestrel: mechanism of action. Obstetrics and Gynecology 2002; 100(1):    65-71.

2. Durand M, del Carmen Cravioto M, Raymond    EG, Duran-Sánchez O, De la Luz Cruz-Hinojosa M, Castell-Rodriguez A, Schiavon    R, Larrea F. On the mechanisms of action of short-term levonorgestrel administration    in emergency contraception. Contraception 2001; 64(4):227-234.

3. Hapangama D, Glasier AF, Baird DT. The    eífects of peri-ovulatory administration of levonorgestrel on the menstrual    cycle. Contraception 2001; 63(3): 123-9.

4. Marions L, Cekan SZ, Bygdeman M. Gemzell-Danielsson    K. Effect of emergency contraception with levonorgestrel or mifepristone on    ovarian ranction. Contraception 2004; 69:373-377.

5. Croxatto HB, Brache V, Pavez m, Cochon    L, Forcelledo ML, Alvarez F, Massai R, Faundes A, Salvatierra AM. Pituitary-ovarian    function following the standard levonorgestrel emergency contraceptive dose    or a single 0.75 mg dose given on the days preceding ovulation. Contraception    2004: 70(6):442-450.

6. Okewole IA, Arowojolu AO, Odusoga OL,    Oloyede OA, Adeleye OA, Salu J, Dada OA. Effect of single administration of    levonorgestrel on the menstrual cycle. Contraception. 2007; 75:372-7

7. Croxatto HB, Devoto L, Durand M, Ezcurra    E, Larrea F, Nagle C, Ortiz ME, Vantman D, Vega M, von Hertzen H. Mechanism    of action of hormonal preparations used for emergency contraception: a review    of the literature. Contraception 2001; 63:111-121

8. Novikova N, Weisberg E, Stanczyk FZ,    Croxatto HB, Fraser IS. Effectiveness of levonorgestrel emergency contraception    given before or after ovulation - a pilot study. Contraception 2007:75:112-118.

9. Meng CX, Andersson KL, Bentin-Ley U,    Gemzell-Danielsson K, Lalitkumar PG. Effect of levonorgestrel and mifepristone    on endometrial receptivity markers in a three-dimensional human endometrial    cell culture model. Fertility and Sterüity 2008 Jan 16 (Epub ahead of print)

10. Durand M, Seppala M, Cravioto M del    C, Koistinen H, Koistinen R, Gonzalez-Macedo J, Larrea F. Late follicular phase    administration of levonorgestrel as an emergency contraceptive changes the secretory    pattern of glycodelin in serum and endometrium during the luteal phase of the    menstrual cycle. Contraception 2005; 71:451-457.

11. Lalitkumar PG, Lalitkumar S, Meng CX,    Stavreus-Evers A. Hambiliki F, Bentin-Ley U, Gemzell-Danielsson K. Mifepristone,    but not levonorgestrel, inhibits human blastocyst attachment to an in vitro    endometrial three-dimensional cell culture model. Human Reproduction 2007; 22(11):    3031-7.

12. Müller A, Liados C, Croxatto HB. Postcoital    treatment with levonorgestrel does not disrupt postfertilization events in the    rat. Contraception 2003; 67:415-419.

13. Ortiz ME, Ortiz RE, Fuentes A, Parraguez    VH, Croxatto HB Post-coital administration of levonorgestrel does not interfere    with post-fertilization events in the new world monkey Cebus apella. Human Reproduction    2004; 19(6):1352-1356.

14. Kesseru E, Camacho-Ortega P, Laudahn    G, Schopfiin G. In vitro action of progestogens on sperm migration in human    cervical mucus. Fertility and Sterüity 1975; 26(1):57-61.

15. Kesseru E, Garmendia F, Westphal N,    Parada J. The hormonal and peripheral eífects of d-norgestrel in postcoital    contraception. Contraception 1974; 10(4): 411-24.

16. Munuce MJ; Nascimento JAA; Rosano G;    Faundes A; Bahamondes L. Doses of levonorgestrel comparable to that delivered    by the levonorgestrel-releasing intrauterine system can modify the in vitro    expression of zona binding sites of human spermatozoa Contraception 2006;73:97-101.

17. Do Nascimento JA, Seppalla M, Perdigao    A, Espejo-Arce X, Munuce MJ, Hautala L, Koistinen R, Andrade L, Bahamondes L.    In vivo assessment of the human sperm acrosome reaction and the expression of    glycodeling-A in human endometrium after levonorgestrel-emergency contraceptive    pill administration. Human Reproduction 2007; 22(8):2190-5.

18. De Santis M, Cavaliere AF, Straface    G, Carducci F, Caruso A. Failure of the emergency contraceptive levonorgestrel    and the risk of adverse eífects in pregnancy and on fetal development: an observational    cohort study. Fertility and Sterüity 2005; 84(2):296-9.

19. Bigrigg A, Evans M, Gbolade B, Newton    J, Poüard L, Szarewski A, Thomas C, Walling M. Depo Provera: Position paper    on clinical use, effectiveness and side eífects. British Journal of Famüy Planning    1999:25(2) 69-76.

ICEC is hosted by Family Gire International           588 Broadway Suite 503, NYNY10012 USA.